HEADER TRANSFERASE/TRANSFERASE INHIBITOR 07-SEP-20 7K1I TITLE EGFR KINASE (L858R/V948R) IN COMPLEX WITH ALLOSTERIC INHIBITOR JBJ-09- TITLE 2 063 COMPND MOL_ID: 1; COMPND 2 MOLECULE: EPIDERMAL GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: PROTO-ONCOGENE C-ERBB-1,RECEPTOR TYROSINE-PROTEIN KINASE COMPND 6 ERBB-1; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: EGFR, ERBB, ERBB1, HER1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PTRIEX KEYWDS EGFR, ERBB1, KINASE, INHIBITOR, TRANSFERASE, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR T.S.BEYETT,M.J.ECK REVDAT 3 18-OCT-23 7K1I 1 REMARK REVDAT 2 18-MAY-22 7K1I 1 JRNL REVDAT 1 15-SEP-21 7K1I 0 JRNL AUTH T.S.BEYETT,C.TO,D.E.HEPPNER,J.K.RANA,A.M.SCHMOKER,J.JANG, JRNL AUTH 2 D.J.H.DE CLERCQ,G.GOMEZ,D.A.SCOTT,N.S.GRAY,P.A.JANNE,M.J.ECK JRNL TITL MOLECULAR BASIS FOR COOPERATIVE BINDING AND SYNERGY OF JRNL TITL 2 ATP-SITE AND ALLOSTERIC EGFR INHIBITORS JRNL REF NAT COMMUN V. 13 2530 2022 JRNL REFN ESSN 2041-1723 JRNL DOI 10.1038/S41467-022-30258-Y REMARK 2 REMARK 2 RESOLUTION. 3.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.11.1_2575 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 53.94 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.380 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 3 NUMBER OF REFLECTIONS : 4798 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.266 REMARK 3 R VALUE (WORKING SET) : 0.263 REMARK 3 FREE R VALUE : 0.311 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.400 REMARK 3 FREE R VALUE TEST SET COUNT : 259 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 53.9360 - 4.0338 0.99 2296 139 0.2414 0.2735 REMARK 3 2 4.0338 - 3.2020 0.98 2243 120 0.3318 0.4095 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.390 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 29.510 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 114.4 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 153.8 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 2485 REMARK 3 ANGLE : 0.818 3373 REMARK 3 CHIRALITY : 0.049 370 REMARK 3 PLANARITY : 0.006 417 REMARK 3 DIHEDRAL : 16.570 1497 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: (CHAIN 'A' AND RESID 700 THROUGH 1007) REMARK 3 ORIGIN FOR THE GROUP (A): 17.3615 -14.9412 8.3435 REMARK 3 T TENSOR REMARK 3 T11: 1.0387 T22: 1.1639 REMARK 3 T33: 0.9985 T12: -0.1849 REMARK 3 T13: -0.0320 T23: -0.3407 REMARK 3 L TENSOR REMARK 3 L11: 6.7740 L22: 3.2383 REMARK 3 L33: 5.6437 L12: 0.1803 REMARK 3 L13: 2.1206 L23: -0.6202 REMARK 3 S TENSOR REMARK 3 S11: -0.1911 S12: 0.1094 S13: -0.1248 REMARK 3 S21: 0.8561 S22: 0.5309 S23: -0.6323 REMARK 3 S31: -1.1769 S32: 2.3652 S33: -0.1959 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7K1I COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-SEP-20. REMARK 100 THE DEPOSITION ID IS D_1000251563. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-DEC-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-E REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9792 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XIA2 REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.4 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 4805 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.200 REMARK 200 RESOLUTION RANGE LOW (A) : 53.940 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : 0.14400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.29 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.3 REMARK 200 DATA REDUNDANCY IN SHELL : 5.80 REMARK 200 R MERGE FOR SHELL (I) : 0.92200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5D41 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 35.04 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.89 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M BIS-TRIS PH 5.5, 28% (W/V) PEG REMARK 280 3350, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 74.01500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 17.90000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 74.01500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 17.90000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5470 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25080 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -47.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 692 REMARK 465 SER A 693 REMARK 465 THR A 694 REMARK 465 SER A 695 REMARK 465 GLY A 696 REMARK 465 GLU A 697 REMARK 465 ALA A 698 REMARK 465 PRO A 699 REMARK 465 ALA A 859 REMARK 465 LYS A 860 REMARK 465 LEU A 861 REMARK 465 LEU A 862 REMARK 465 GLY A 863 REMARK 465 ALA A 864 REMARK 465 GLU A 865 REMARK 465 GLU A 866 REMARK 465 LYS A 867 REMARK 465 GLU A 868 REMARK 465 TYR A 869 REMARK 465 HIS A 870 REMARK 465 ALA A 871 REMARK 465 GLU A 872 REMARK 465 GLY A 873 REMARK 465 GLY A 874 REMARK 465 LYS A 875 REMARK 465 LEU A 887 REMARK 465 HIS A 888 REMARK 465 ARG A 889 REMARK 465 ASP A 1008 REMARK 465 ASP A 1009 REMARK 465 VAL A 1010 REMARK 465 VAL A 1011 REMARK 465 ASP A 1012 REMARK 465 ALA A 1013 REMARK 465 ASP A 1014 REMARK 465 GLU A 1015 REMARK 465 TYR A 1016 REMARK 465 LEU A 1017 REMARK 465 ILE A 1018 REMARK 465 PRO A 1019 REMARK 465 GLN A 1020 REMARK 465 GLN A 1021 REMARK 465 GLY A 1022 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 783 -166.62 -70.68 REMARK 500 ARG A 836 -7.58 76.66 REMARK 500 ASP A 837 57.35 -153.46 REMARK 500 HIS A 988 -135.65 -154.51 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A1101 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN A 842 OD1 REMARK 620 2 ASP A 855 OD2 92.0 REMARK 620 3 ANP A1102 O2G 74.5 88.8 REMARK 620 4 ANP A1102 O2A 151.9 87.6 77.4 REMARK 620 5 ANP A1102 O1B 83.2 158.3 69.5 86.8 REMARK 620 N 1 2 3 4 DBREF 7K1I A 695 1022 UNP P00533 EGFR_HUMAN 695 1022 SEQADV 7K1I GLY A 692 UNP P00533 EXPRESSION TAG SEQADV 7K1I SER A 693 UNP P00533 EXPRESSION TAG SEQADV 7K1I THR A 694 UNP P00533 EXPRESSION TAG SEQADV 7K1I ARG A 858 UNP P00533 LEU 858 ENGINEERED MUTATION SEQADV 7K1I ARG A 948 UNP P00533 VAL 948 ENGINEERED MUTATION SEQRES 1 A 331 GLY SER THR SER GLY GLU ALA PRO ASN GLN ALA LEU LEU SEQRES 2 A 331 ARG ILE LEU LYS GLU THR GLU PHE LYS LYS ILE LYS VAL SEQRES 3 A 331 LEU GLY SER GLY ALA PHE GLY THR VAL TYR LYS GLY LEU SEQRES 4 A 331 TRP ILE PRO GLU GLY GLU LYS VAL LYS ILE PRO VAL ALA SEQRES 5 A 331 ILE LYS GLU LEU ARG GLU ALA THR SER PRO LYS ALA ASN SEQRES 6 A 331 LYS GLU ILE LEU ASP GLU ALA TYR VAL MET ALA SER VAL SEQRES 7 A 331 ASP ASN PRO HIS VAL CYS ARG LEU LEU GLY ILE CYS LEU SEQRES 8 A 331 THR SER THR VAL GLN LEU ILE THR GLN LEU MET PRO PHE SEQRES 9 A 331 GLY CYS LEU LEU ASP TYR VAL ARG GLU HIS LYS ASP ASN SEQRES 10 A 331 ILE GLY SER GLN TYR LEU LEU ASN TRP CYS VAL GLN ILE SEQRES 11 A 331 ALA LYS GLY MET ASN TYR LEU GLU ASP ARG ARG LEU VAL SEQRES 12 A 331 HIS ARG ASP LEU ALA ALA ARG ASN VAL LEU VAL LYS THR SEQRES 13 A 331 PRO GLN HIS VAL LYS ILE THR ASP PHE GLY ARG ALA LYS SEQRES 14 A 331 LEU LEU GLY ALA GLU GLU LYS GLU TYR HIS ALA GLU GLY SEQRES 15 A 331 GLY LYS VAL PRO ILE LYS TRP MET ALA LEU GLU SER ILE SEQRES 16 A 331 LEU HIS ARG ILE TYR THR HIS GLN SER ASP VAL TRP SER SEQRES 17 A 331 TYR GLY VAL THR VAL TRP GLU LEU MET THR PHE GLY SER SEQRES 18 A 331 LYS PRO TYR ASP GLY ILE PRO ALA SER GLU ILE SER SER SEQRES 19 A 331 ILE LEU GLU LYS GLY GLU ARG LEU PRO GLN PRO PRO ILE SEQRES 20 A 331 CYS THR ILE ASP VAL TYR MET ILE MET ARG LYS CYS TRP SEQRES 21 A 331 MET ILE ASP ALA ASP SER ARG PRO LYS PHE ARG GLU LEU SEQRES 22 A 331 ILE ILE GLU PHE SER LYS MET ALA ARG ASP PRO GLN ARG SEQRES 23 A 331 TYR LEU VAL ILE GLN GLY ASP GLU ARG MET HIS LEU PRO SEQRES 24 A 331 SER PRO THR ASP SER ASN PHE TYR ARG ALA LEU MET ASP SEQRES 25 A 331 GLU GLU ASP MET ASP ASP VAL VAL ASP ALA ASP GLU TYR SEQRES 26 A 331 LEU ILE PRO GLN GLN GLY HET MG A1101 1 HET ANP A1102 31 HET VNS A1103 40 HETNAM MG MAGNESIUM ION HETNAM ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER HETNAM VNS (2R)-2-(5-FLUORO-2-HYDROXYPHENYL)-2-{6-[4-(1- HETNAM 2 VNS METHYLPIPERIDIN-4-YL)PHENYL]-1-OXO-1,3-DIHYDRO-2H- HETNAM 3 VNS ISOINDOL-2-YL}-N-(1,3-THIAZOL-2-YL)ACETAMIDE FORMUL 2 MG MG 2+ FORMUL 3 ANP C10 H17 N6 O12 P3 FORMUL 4 VNS C31 H29 F N4 O3 S HELIX 1 AA1 ASN A 700 LEU A 704 5 5 HELIX 2 AA2 LYS A 708 THR A 710 5 3 HELIX 3 AA3 SER A 752 ALA A 767 1 16 HELIX 4 AA4 CYS A 797 LYS A 806 1 10 HELIX 5 AA5 GLY A 810 ARG A 831 1 22 HELIX 6 AA6 ALA A 839 ARG A 841 5 3 HELIX 7 AA7 PRO A 877 MET A 881 5 5 HELIX 8 AA8 THR A 892 THR A 909 1 18 HELIX 9 AA9 PRO A 919 SER A 921 5 3 HELIX 10 AB1 GLU A 922 LYS A 929 1 8 HELIX 11 AB2 THR A 940 CYS A 950 1 11 HELIX 12 AB3 ASP A 954 ARG A 958 5 5 HELIX 13 AB4 LYS A 960 ARG A 973 1 14 HELIX 14 AB5 ASP A 974 LEU A 979 1 6 HELIX 15 AB6 SER A 991 ASP A 1003 1 13 SHEET 1 AA1 6 ARG A 705 ILE A 706 0 SHEET 2 AA1 6 GLY A 779 LEU A 782 1 O ILE A 780 N ARG A 705 SHEET 3 AA1 6 VAL A 786 THR A 790 -1 O GLN A 787 N CYS A 781 SHEET 4 AA1 6 ILE A 740 LEU A 747 -1 N LYS A 745 O LEU A 788 SHEET 5 AA1 6 GLY A 724 TRP A 731 -1 N TRP A 731 O ILE A 740 SHEET 6 AA1 6 PHE A 712 GLY A 721 -1 N GLY A 719 O VAL A 726 SHEET 1 AA2 2 VAL A 843 THR A 847 0 SHEET 2 AA2 2 HIS A 850 ILE A 853 -1 O LYS A 852 N LEU A 844 LINK OD1 ASN A 842 MG MG A1101 1555 1555 2.32 LINK OD2 ASP A 855 MG MG A1101 1555 1555 2.13 LINK MG MG A1101 O2G ANP A1102 1555 1555 2.12 LINK MG MG A1101 O2A ANP A1102 1555 1555 1.79 LINK MG MG A1101 O1B ANP A1102 1555 1555 1.94 CRYST1 148.030 35.800 54.800 90.00 100.19 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006755 0.000000 0.001214 0.00000 SCALE2 0.000000 0.027933 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018541 0.00000